As the scientific community continues to explore this promising avenue, one thing is clear: the future of cancer care lies at the intersection of innovation, ... Dec 12
Innovative approach of Medanta experts offer new hope for complex, aggressive cancer cases... Dec 03
These findings reflect the ongoing commitment of the medical community to improving outcomes for patients, while also leading the way for future innovations in diagnosis, ... Sep 17
This innovative approach not only offers advanced therapeutic options to cancer patients but also addresses the affordability and accessibility challenges associated with life-saving treatments. ... Dec 06
In a significant development, the World Health Organization (WHO) has recently released the 23rd edition of the Model Lists of Essential Medicines (EML) and the ... Aug 01
The biotech sector in the country has been seeing a lot of activity, and the government is also promoting startups in the industry. Immuneel Therapeutics ... Jun 23
Latest pharma news update... Sep 16
The new drug is an Allogeneic CAR-T Candidate for Relapsed/Refractory Multiple Myeloma... Sep 03
Pharma merger and acquisition news... Jul 22
New approval for treating leukomia... Jun 22
Tessa announced, EMA has granted PRiority MEdicines designation to the company's lead autologous CD30 CAR-T therapy for the treatment of relapsed or refractory ... Jan 19
first-ever approved site for commercial CAR-T cell therapy manufacturing in Asia... Oct 31
NKMax America has developed a proprietary NK cell expansion and activation technology platform which allows it to produce unprecedented commercial amounts of autologous and allogeneic ... Oct 20
Approximately 100 hospitalized volunteers will be assigned to each study arm with each of the study sites testing no more than three investigational treatments at ... Oct 14
WindMIL Therapeutics and Stephenson Cancer Center announce collaboration to collect bone marrow from patients with renal and urothelial carcinomas ... Oct 14
Novel CAR-T Cell immunotherapy for lymphoma advances to phase II clinical trial ... Oct 06
Manufacturing agreement for Autologous T-Cell Receptor-Based Cell Therapy... Sep 24
Takeda establishes new cell drug manufacturing facility for research and development to support expansion of next-generation clinical programs ... Sep 19
Elicio Therapeutics and Moffitt Collaborate to study AMP-CD19 in combination with CD19 CAR T cells ... Sep 18
Catalent and Astrazeneca partners for the Covid vaccine manufacturing... Aug 26
The new multiplex cytokine and cytotoxicity assays as a part of the Opto Cell Therapy Development 1.0 workflow will help users of the Berkeley ... Apr 28
New Danaher operating company created following completion of $21.4B acquisition by Danaher Corporation,Cytiva will help accelerate growth and innovation in biological therapies... Apr 01
Servier, an independent international pharmaceutical company, today announced the acquisition of PIXUVRI® from CTI BioPharma.... Oct 01
-Advertisements-
.jpeg)
Thursday, April 10, 2025
.jpeg)
.jpeg)
.jpeg)
.jpg)
.jpeg)
.jpeg)
.jpeg)
.jpg)
